SNBL’s nasal drug delivery platform is a proprietary system consisting of powder carrier technology and delivery device technology.
3D Nasal Cast Model
For Admin
Translational Research
Business
A Leading Company in Nasal Drug Delivery
| Seminar |
The 505(b)(2) Forum (http://www.505b2forum.com/) -THE 505(B)(2) PATHWAY: A CASE-BY-CASE REVIEW OF NEW TECHNOLOGIES AND DEVELOPMENT TECHNIQUES- |
|---|---|
| Title |
OBTAINING FDA ACCEPTANCE FOR TWO DIFFERENTIATED NASAL ABSORPTION DELIVERIES WITHOUT PHASE III |
| Date | Monday, October 27, 2014, 18:30 - 21:00 |
| Site | Bethesda North Marriott Hotel and Conference Center, North Bethesda, MD, USA |
In conjunction with Camargo Pharmaceutical Services, leaders in the area of 505(b)(2) development programs, SNBL will present our experience of two programs using SNBL's μco™ System, which obtained the FDA's acceptance for approval without Phase 3 clinical efficacy studies.
For more information, click here.
The 505(b)(2) Forum was organized by product developers and service providers interested in improving best practices across the 505(b)(2) development process. This forum will be held during the GPhA Fall Technical Conference.